Antigoni Koukkoulli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antigoni Koukkoulli has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Aman Chandra
Department of Education, Moorfields Eye Hospital, London, United Kingdom
1 shared publicationB Y P Chang
Department of Ophthalmology, St James’s University Hospital, Leeds, UK
1 shared publication- Daniel G. Ezra
Moorfields Eye Hospital, London, UK.
1 shared publication Fayyaz Musa
Huddersfield Royal Infirmary
1 shared publicationG Kalantzis
Department of Ophthalmology, St James’s University Hospital, Leeds, UK
1 shared publicationHithen Sheth
Department of Education, Moorfields Eye Hospital, London, United Kingdom
1 shared publication
Latest Publications
- 1 July 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (4) , 585-591
Bridging the Gap: Theory-Based Design of a Microsurgical Skills Course for Ophthalmology Residents
- 1 July 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (4) , 585-591
Bridging the Gap: Theory-Based Design of a Microsurgical Skills Course for Ophthalmology Residents
- 11 October 2014
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 253 (1) , 99-106
Long-term outcomes of needle revision of failing deep sclerectomy blebs
To report on long-term outcomes of mitomycin C (MMC)-augmented needle revision of failing deep sclerectomy (DS) blebs. Retrospective database search of all needle revisions with MMC for DS blebs between 2002 and 2008 was conducted. Sixty-six eyes of 66 patients were included in the study. Subconjunctival MMC 0.01–0.02 mg was injected 15 min before needle revision. Complete success was defined as intraocular pressure ≤ 18 mmHg or 20 % decrease from baseline with no glaucoma medications or further surgical procedures. Partial success was based on the same criteria, but with medications. Mean follow-up after index needle revision was 67.8 ± 24.8 months (range 1–10 years). The mean number of needle revisions was 1.6 ± 0.8 (range 1–4). Two or more procedures were done in 31 eyes (47.0 %). Mean preoperative intraocular pressure was 23.2 ± 6.9 mmHg. Complete and partial success rates were 64 % and 71 % at 1 year, 57 % and 68 % at 3 years, and 40 % and 58 % at 5 years after surgery, respectively. Early needle revision, within 6 months of index surgery, was significantly associated with failure, both on uni- and multivariate tests. Significant complications included delayed hypotony in five eyes (7.6 %), delayed bleb leak in two eyes (3.0 %), endophthalmitis in one eye (1.5 %), and corneal oedema in two eyes (3.0 %). Needle revision with subconjunctival MMC may successfully lower the intraocular pressure in eyes with a failing DS bleb in the long term. Complications known to be associated with trabeculectomy and MMC were anticipated and observed in our DS group.
- 11 October 2014
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 253 (1) , 99-106
Long-term outcomes of needle revision of failing deep sclerectomy blebs
To report on long-term outcomes of mitomycin C (MMC)-augmented needle revision of failing deep sclerectomy (DS) blebs. Retrospective database search of all needle revisions with MMC for DS blebs between 2002 and 2008 was conducted. Sixty-six eyes of 66 patients were included in the study. Subconjunctival MMC 0.01–0.02 mg was injected 15 min before needle revision. Complete success was defined as intraocular pressure ≤ 18 mmHg or 20 % decrease from baseline with no glaucoma medications or further surgical procedures. Partial success was based on the same criteria, but with medications. Mean follow-up after index needle revision was 67.8 ± 24.8 months (range 1–10 years). The mean number of needle revisions was 1.6 ± 0.8 (range 1–4). Two or more procedures were done in 31 eyes (47.0 %). Mean preoperative intraocular pressure was 23.2 ± 6.9 mmHg. Complete and partial success rates were 64 % and 71 % at 1 year, 57 % and 68 % at 3 years, and 40 % and 58 % at 5 years after surgery, respectively. Early needle revision, within 6 months of index surgery, was significantly associated with failure, both on uni- and multivariate tests. Significant complications included delayed hypotony in five eyes (7.6 %), delayed bleb leak in two eyes (3.0 %), endophthalmitis in one eye (1.5 %), and corneal oedema in two eyes (3.0 %). Needle revision with subconjunctival MMC may successfully lower the intraocular pressure in eyes with a failing DS bleb in the long term. Complications known to be associated with trabeculectomy and MMC were anticipated and observed in our DS group.
- 1 March 2013
- Published by Springer Nature in Eye
- Vol. 27 (5) , 675-676
An unusual presentation of aqueous misdirection
- 1 March 2013
- Published by Springer Nature in Eye
- Vol. 27 (5) , 675-676
An unusual presentation of aqueous misdirection
- 29 January 2013
- Published by Springer Nature in International Ophthalmology
- Vol. 34 (1) , 81-84
The use of Densiron-68™ as a perioperative surgical tool
Agents such as Densiron-68™, with specific gravity slightly greater than that of water (1.06 g/cm3), have been developed to tamponade the inferior retina following retinal detachment repair procedures. The minimal force that would result from the sinking of such an agent in balanced saline solution is not considered sufficient to permit the use of Densiron-68™ as a surgical tool to displace subretinal fluid and stabilise the retina perioperatively. We report five cases where Densiron-68™ was instilled directly into a saline-filled eye with an unstable retinal detachment. The detachment was reduced and the Densiron-68™ left in situ. Four cases involved giant retinal tears and the fifth an inferior retinal detachment with no breaks identified. The injection of Densiron-68™ as a single manoeuvre to flatten the retina and to simultaneously provide postoperative tamponade was successfully used in these five patients. Six months after removal of Densiron-68™ the retina remained flat in all five cases. This previously unfamiliar technique provides an additional surgical option to gain control in cases of complicated retinal detachment with a mobile retina, especially if inferior tamponade is required.
- 29 January 2013
- Published by Springer Nature in International Ophthalmology
- Vol. 34 (1) , 81-84
The use of Densiron-68™ as a perioperative surgical tool
Agents such as Densiron-68™, with specific gravity slightly greater than that of water (1.06 g/cm3), have been developed to tamponade the inferior retina following retinal detachment repair procedures. The minimal force that would result from the sinking of such an agent in balanced saline solution is not considered sufficient to permit the use of Densiron-68™ as a surgical tool to displace subretinal fluid and stabilise the retina perioperatively. We report five cases where Densiron-68™ was instilled directly into a saline-filled eye with an unstable retinal detachment. The detachment was reduced and the Densiron-68™ left in situ. Four cases involved giant retinal tears and the fifth an inferior retinal detachment with no breaks identified. The injection of Densiron-68™ as a single manoeuvre to flatten the retina and to simultaneously provide postoperative tamponade was successfully used in these five patients. Six months after removal of Densiron-68™ the retina remained flat in all five cases. This previously unfamiliar technique provides an additional surgical option to gain control in cases of complicated retinal detachment with a mobile retina, especially if inferior tamponade is required.
- 23 November 2012
- Published by Springer Nature in Eye
- Vol. 27 (1) , 104-105
Oncocytic adenocarcinoma of the lacrimal gland: an unusual presentation
- 23 November 2012
- Published by Springer Nature in Eye
- Vol. 27 (1) , 104-105
Oncocytic adenocarcinoma of the lacrimal gland: an unusual presentation